Literature DB >> 12909822

[Diagnosis of adult chronic kidney failure].

.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12909822     DOI: 10.1016/s1262-3636(07)70043-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  3 in total

1.  Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease.

Authors:  Vincent Rigalleau; Magalie Garcia; Catherine Lasseur; François Laurent; Michel Montaudon; Christelle Raffaitin; Nicole Barthe; Marie-Christine Beauvieux; Benoit Vendrely; Philippe Chauveau; Christian Combe; Henri Gin
Journal:  BMC Nephrol       Date:  2010-03-03       Impact factor: 2.388

2.  Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.

Authors:  João Pedro Ferreira; Nicolas Girerd; Pierpaolo Pellicori; Kevin Duarte; Sophie Girerd; Marc A Pfeffer; John J V McMurray; Bertram Pitt; Kenneth Dickstein; Lotte Jacobs; Jan A Staessen; Javed Butler; Roberto Latini; Serge Masson; Alexandre Mebazaa; Hans Peter Brunner-La Rocca; Christian Delles; Stephane Heymans; Naveed Sattar; J Wouter Jukema; John G Cleland; Faiez Zannad; Patrick Rossignol
Journal:  BMC Med       Date:  2016-11-10       Impact factor: 8.775

3.  Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial.

Authors:  Pascale Boissonnat; Ségolène Gaillard; Catherine Mercier; Michel Redonnet; Bernard Lelong; Marie-Françoise Mattei; Annick Mouly-Bandini; Sabine Pattier; Agnès Sirinelli; Eric Epailly; Shaida Varnous; Marc-Alain Billes; Laurent Sebbag; René Ecochard; Catherine Cornu; François Gueyffier
Journal:  Trials       Date:  2012-12-03       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.